The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A Hyaluronic Acid−Taxol Antitumor Bioconjugate Targeted to Cancer Cells
Abstract
A cell-targeted polymeric prodrug prepared from Taxol and chemically modified hyaluronic acid (HA) was evaluated in vitro. Herein we report four results in support of the selective uptake and targeted toxicity of the HA-Taxol prodrug. First, a fluorescently labeled HA-Taxol (FITC-HA-Taxol) was synthesized and used to demonstrate cell-specific binding and uptake using flow cytometry and confocal microscopy. Second, the selective cytotoxicity of FITC-HA-Taxol allowed direct correlation of uptake with selective cytotoxicity. Third, the rapid uptake and selective cytotoxicity of HA-Taxol bioconjugates could be blocked by either excess HA or by an anti-CD44 antibody, but not by chondroitin sulfate (CS). Finally, the release of free Taxol from HA-Taxol in human plasma or in cell culture media revealed that the free drug was hydrolytically released from the bioconjugate by cleavage of the labile 2' ester linkage. Taken together, these data support the notion that the targeted cytotoxicity of HA-Taxol bioconjugates requires receptor-mediated cellular uptake of the bioconjugate followed by hydrolytic release of free Taxol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyaluronan‐binding proteins in development, tissue homeostasis, and disease
Knudson, C. B., & Knudson, W. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.13.7691670 · Cited by 649
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
HA receptors: Regulators of signalling to the cytoskeleton
Entwistle, J., Hall, C. L., & Turley, E. A. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<569::aid-jcb10>3.0.co;2-b · Cited by 472
The chemistry, biology and medical applications of hyaluronan and its derivatives
Balazs, E. A., & Laurent, T. C. (1998) · Portland eBooks · Cited by 447
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
Culty, M., Nguyen, H. A., & Underhill, C. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.4.1055 · Cited by 395
Hyaluronidases - a group of neglected enzymes
Kreil, G. (1995) · Protein Science · doi:10.1002/pro.5560040902 · Cited by 343
Toole, B. P. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00171.x · Cited by 320
Laurent, T. C., Laurent, U. B., & Fraser, J. R. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.5.429 · Cited by 305
The role of hyaluronan in tumour neovascularization (review)
Rooney, P., Kumar, S., Ponting, J., & Wang, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600511 · Cited by 271
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Trouet, A., Masquelier, M., Baurain, R., & Deprez-De Campeneere, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.2.626 · Cited by 233
Nanoparticle-based dmg delivery systems
Kreuter, J. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90040-k · Cited by 203
Lesley, J., English, N., Perschl, A., Gregoroff, J., & Hyman, R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.431 · Cited by 196
CD44 in inflammation and metastasis
Lesley, J., Hyman, R., English, N., Catterall, J. B., & Turner, G. A. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018540610858 · Cited by 194
Hyaluronate Derivatives in Drug Delivery
Vercruysse, K. P., & Prestwich, G. D. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i5.30 · Cited by 190
Self-citationCulty, M., Shizari, M., Thompson, E. W., & Underhill, C. B. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600209 · Cited by 161
CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells
Lesley, J., & Hyman, R. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221036 · Cited by 142
Albumin microspheres and microcapsules: Methodology of manufacturing techniques
Arshady, R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90149-n · Cited by 139
Lesley, J., Kincade, P. W., & Hyman, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230826 · Cited by 121
Carbohydrate-Protein Interactions in Vascular Biology
Nelson, R. M., Venot, A. P., Bevilacqua, M. P., Linhardt, R. J., & Stamenkovic, I. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.003125 · Cited by 115
Collis, L., Hall, C. L., Lange, L., Ziebell, M. R., Prestwich, R. J. D., & Turley, E. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01505-1 · Cited by 112
Self-citationTurley, E., Belch, A., Poppema, S., & Pilarski, L. (1993) · Blood · doi:10.1182/blood.v81.2.446.446 · Cited by 89
Akima, K., Ito, H., Iwata, Y., et al. (1996) · Journal of drug targeting · doi:10.3109/10611869609046255 · Cited by 78
Iida, N., & Bourguignon, L. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199705)171:2<152::aid-jcp5>3.0.co;2-n · Cited by 66
Waser, P. G., Müller, U., Kreuter, J., Berger, S., Munz, K., Kaiser, E., & Pfluger, B. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90219-5 · Cited by 58
Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers
Cartlidge, S. A., Duncan, R., Lloyd, J. B., Kopečkova—Rejmanová, P., & Kopec̆ek, J. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90018-6 · Cited by 49
Hirano, T., Ohashi, S., Morimoto, S., Tsuda, K., Kobayashi, T., & Tsukagoshi, S. (1986) · Die Makromolekulare Chemie · doi:10.1002/macp.1986.021871208 · Cited by 42
Studies on the interaction between hyaluronan and a rat colon cancer cell line
Samuelsson, C., & Gustafson, S. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006920323095 · Cited by 19
Cell-Based Screen for Identification of Inhibitors of Tubulin Polymerization
Kokoshka, J. M., Ireland, C. M., & Barrows, L. R. (1996) · Journal of Natural Products · doi:10.1021/np960144k · Cited by 15
Nakabayashi, H., Tsujii, H., OKAMOTO, Y., & Nakano, H. (1996) · International Hepatology Communications · doi:10.1016/0928-4346(96)00318-0 · Cited by 4
Cited by
Main properties and current applications of some polysaccharides as biomaterials
Rinaudo, M. (2008) · Polymer International · doi:10.1002/pi.2378 · Cited by 1,028
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Schanté, C. E., Zuber, G., Herlin, C., & Vandamme, T. F. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.03.019 · Cited by 708
The magic glue hyaluronan and its eraser hyaluronidase: A biological overview
Girish, K. S., & Kemparaju, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.037 · Cited by 674
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications
Cunha, L., & Grenha, A. (2016) · Marine Drugs · doi:10.3390/md14030042 · Cited by 611
Metadata
- Authors
- Luo, Y., Ziebell, M. R., & Prestwich, G. D.
- Venue
- Biomacromolecules
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-03-25
- Volume
- 1
- Issue
- 2
- Pages
- 208-218
- ISSN
- 1525-7797 (ISSN-L)
- 1526-4602
- OpenAlex
- W1978235057
- Cited by
- 261
- References
- 31
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.